Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
82.51
+0.26 (0.32%)
Nov 3, 2026, 3:49 PM EST - Market open
Dianthus Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $113 | Buy | Initiates | $113 | +36.95% | Oct 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $135 | Buy | Maintains | $135 | +63.62% | Oct 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $158 | Buy | Reiterates | $158 | +91.49% | Oct 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 | Buy | Maintains | $125 | +51.50% | Sep 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 24, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 18, 2026 |
| Citi | Citi | Buy Initiates $156 | Buy | Initiates | $156 | +89.07% | Sep 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $133 | Buy | Maintains | $133 | +61.19% | Aug 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.